METTL3 and chronic myelogenous leukemia, BCR-ABL1 positive: Altogether, these data indicate that in CML METTL3 controls MYC expression at multiple levels; thus, indicating that the downregulation of genes involved in RNA metabolism observed in the RNA-seq is due, at least in part, to the loss of MYC transcriptional activity.